Works matching DE "INFLIXIMAB"

Results: 3319

TRANSFORMING TREATMENT.

Published in:

Podiatrist, 2025, v. 28, n. 3, p. 31

By:

Oxtoby, Kathy

Publication type:

Article

Comparing Long‐Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.

Published in:

Journal of Gastroenterology & Hepatology, 2025, v. 40, n. 5, p. 1174, doi. 10.1111/jgh.16916

By:

Suo, Paulina;
Srinivasan, Ashish;
Thin, Lena;
An, Yoon‐Kyo;
Fernandes, Richard G.;
Ghaly, Simon;
Jeffrey, Angus W.;
Menon, Shankar;
Olsen, Nicholas;
Skinner, Thomas;
van Langenberg, Daniel R.;
Winston, James;
Haifer, Craig

Publication type:

Article

IgA Nephropathy Associated With Infliximab Treatment in Patients With Crohn’s Disease: Study of IgA1 and IgA2 Expression in Glomeruli.

Published in:

In Vivo, 2025, v. 39, n. 3, p. 1731, doi. 10.21873/invivo.13975

By:

AKIRA MIMA;
TAKAHIRO NAKAMOTO;
TAKAMASA MATSUKI;
SUGURU KIDO;
YUTA SAITO;
TAKAAKI MORIKAWA;
KEISHI MATSUMOTO;
HIDEMASA GOTODA;
SHINJI LEE

Publication type:

Article

Clinico-epidemiological profile of reactive arthritis patients attending tertiary care center of Eastern India.

Published in:

Indian Journal of Dermatology, Venereology & Leprology, 2025, v. 91, p. 1, doi. 10.25259/IJDVL_1189_2023

By:

Pradhan, Swetalina;
Shahid, Rashid

Publication type:

Article

What is the association between the tumor necrosis factor-α inhibitor infliximab and complex regional pain syndrome type I?

Published in:

2008

By:

Paraskevas, Kosmas I.

Publication type:

Letter

Meeting Reporter.

Published in:

Patient Care (Print), 2006, v. 40, n. 9, p. 10

By:

Asch-Goodkin, Judith;
Kaplan, Deborah

Publication type:

Article

Prescribing Update.

Published in:

Patient Care (Print), 2002, v. 36, n. 7, p. 85

By:

Saunders, Carol S.

Publication type:

Article

Stable expression of infliximab in CRISPR/Cas9-mediated BAK1-deficient CHO cells.

Published in:

Biotechnology Letters, 2018, v. 40, n. 8, p. 1209, doi. 10.1007/s10529-018-2578-4

By:

Miao, Zhi;
Li, Qian;
Zhao, Jian;
Wang, Peng;
Wang, Lei;
He, Hong-Peng;
Wang, Nan;
Zhou, Hao;
Zhang, Tong-Cun;
Luo, Xue-Gang

Publication type:

Article

Fulminant hepatic failure necessitating transplantation following the initiation of infliximab therapy: a cautionary tale times two.

Published in:

Transplant International, 2013, v. 26, n. 12, p. e110, doi. 10.1111/tri.12185

By:

Rowe, Bradley W.;
Gala-Lopez, Boris;
Tomlinson, Corey;
Girgis, Safwat;
Shapiro, James A. M.

Publication type:

Article

Inhibition of TNF-α reduces transplant arteriosclerosis in a murine aortic transplant model.

Published in:

Transplant International, 2009, v. 22, n. 3, p. 342, doi. 10.1111/j.1432-2277.2008.00802.x

By:

Wollin, Martina;
Abele, Silke;
Bruns, Heiko;
Weyand, Michael;
Kalden, Joachim R.;
Ensminger, Stephan M.;
Spriewald, Bernd M.

Publication type:

Article

Effect of TNF-α inhibition on urinary albumin excretion in experimental diabetic rats.

Published in:

Acta Diabetologica, 2007, v. 44, n. 4, p. 215, doi. 10.1007/s00592-007-0007-6

By:

Moriwaki, Yuji;
Inokuchi, Taku;
Yamamoto, Asako;
Ka, Tsuneyoshi;
Tsutsumi, Zenta;
Takahashi, Sumio;
Yamamoto, Tetsuya

Publication type:

Article

Structure-based development and optimization of therapy antibody drugs against TNFα.

Published in:

Amino Acids, 2015, v. 47, n. 6, p. 1259, doi. 10.1007/s00726-015-1954-9

By:

Fu, Wenyan;
Wang, Xiaoze;
Yang, Weili;
Takeda, Hiroaki;
Hu, Shi;
Lou, Zhiyong;
Zhao, Jian;
Bethune, Augus;
Guo, Yajun

Publication type:

Article

Infliximab as a Rescue Therapy for Hospitalized Patients with Severe Ulcerative Colitis Refractory to Systemic Corticosteroids.

Published in:

Digestive Surgery, 2008, v. 25, n. 5, p. 383, doi. 10.1159/000170882

By:

Yamamoto-Furusho, Jesús K.;
Uzcanga, Luis F.

Publication type:

Article

Plasma Oncostatin M, TNF-α, IL-7, and IL-13 Network Predicts Crohn's Disease Response to Infliximab, as Assessed by Calprotectin Log Drop.

Published in:

Digestive Diseases, 2021, v. 39, n. 1, p. 1, doi. 10.1159/000508069

By:

Mateos, Beatriz;
Sáez-González, Esteban;
Moret, Inés;
Hervás, David;
Iborra, Marisa;
Cerrillo, Elena;
Tortosa, Luis;
Nos, Pilar;
Beltrán, Belén

Publication type:

Article

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.

Published in:

Digestive Diseases, 2019, v. 37, n. 2, p. 108, doi. 10.1159/000492626

By:

Beltrán, Belén;
Iborra, Marisa;
Sáez-González, Esteban;
Marqués-Miñana, Maria R.;
Moret, Inés;
Cerrillo, Elena;
Tortosa, Luis;
Bastida, Guillermo;
Hinojosa, Joaquín;
Poveda-Andrés, Jose Luis;
Nos, Pilar

Publication type:

Article

Efficacy and Safety of Infliximab Tolerance Induction in Patients with Inflammatory Bowel Diseases who Experienced Acute Infusion Reactions.

Published in:

Digestive Diseases, 2018, v. 36, n. 6, p. 417, doi. 10.1159/000491078

By:

Pauchard, Isabelle;
Nancey, Stéphane;
Hacard, Florence;
Williet, Nicolas;
Roblin, Xavier;
Moussata, Driffa;
Bérard, Frédéric;
Flourié, Bernard;
Boschetti, Gilles

Publication type:

Article

Comparison of Safety and Efficacy of Tacrolimus versus Infliximab for Active Ulcerative Colitis.

Published in:

Digestive Diseases, 2018, v. 36, n. 2, p. 106, doi. 10.1159/000481815

By:

Takeuchi, Ken;
Shimoyama, Takahiro;
Yamamoto, Takayuki

Publication type:

Article

Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors.

Published in:

Digestive Diseases, 2018, v. 36, n. 1, p. 40, doi. 10.1159/000477962

By:

Ohem, Jan;
Hradsky, Ondrej;
Zarubova, Kristyna;
Copova, Ivana;
Bukovska, Petra;
Prusa, Richard;
Malickova, Karin;
Bronsky, Jiri

Publication type:

Article

Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors.

Published in:

Digestive Diseases, 2017, v. 35, n. 6, p. 40, doi. 10.1159/000477962

By:

Ohem, Jan;
Hradsky, Ondrej;
Zarubova, Kristyna;
Copova, Ivana;
Bukovska, Petra;
Prusa, Richard;
Malickova, Karin;
Bronsky, Jiri

Publication type:

Article

Emerging Biological Treatments in Inflammatory Bowel Diseases.

Published in:

Digestive Diseases, 2006, v. 24, n. 1/2, p. 131, doi. 10.1159/000090316

By:

Van Assche, Gert;
Vermeire, Séverine;
Rutgeerts, Paul

Publication type:

Article

Infliximab Therapy Improves the Bone Metabolism in Fistulizing Crohn’s Disease.

Published in:

Digestive Diseases, 2006, v. 24, n. 1/2, p. 201, doi. 10.1159/000091299

By:

Miheller, Pal;
Müzes, Gyorgyi;
Zagoni, Tamas;
Toth, Miklos;
Racz, Karoly;
Tulassay, Zsolt

Publication type:

Article

Standard Treatment of Ulcerative Colitis.

Published in:

Digestive Diseases, 2003, v. 21, n. 2, p. 157, doi. 10.1159/000073247

By:

Gionchetti, Paolo;
Rizzello, Fernando;
Habal, Flavio;
Morselli, Claudia;
Amadini, Cristina;
Romagnoli, Rossella;
Campieri, Massimo

Publication type:

Article

Standard Therapy of Crohn's Disease.

Published in:

Digestive Diseases, 2003, v. 21, n. 2, p. 146, doi. 10.1159/000073246

By:

Miehsler, Wolfgang;
Gasche, Christoph

Publication type:

Article

Infliximab: A treatment option for multisystem inflammatory syndrome in children with ulcerative colitis?

Published in:

Turkish Archives of Pediatrics, 2021, v. 56, n. 3, p. 267, doi. 10.5152/TurkArchPediatr.2021.21057

By:

Alkan, Gulsum;
Emiroglu, Melike;
Tuter Oz, Sadiye Kubra;
Ergani, Anna Carina;
Emiroglu, Halil Haldun

Publication type:

Article

Assessment of the efficacy of biological treatment in acne inversa.

Published in:

Forum Dermatologicum, 2024, v. 10, n. 3, p. 79, doi. 10.5603/fd.101083

By:

Anioła, Aleksandra;
Ważniewicz, Sandra;
Jonkisz, Aleksandra;
Płotast, Magdalena;
Jałowska, Magdalena

Publication type:

Article

Diagnostics difficulties in mycosis fungoides — a case report.

Published in:

Forum Dermatologicum, 2023, v. 9, n. 2, p. 78, doi. 10.5603/FD.a2023.0012

By:

Kędra, Kamila;
Ostańska, Elżbieta;
Reich, Adam

Publication type:

Article

Analiza dostępu do leczenia pacjentów z łuszczycą w ramach programu lekowego B.47 „Leczenie umiarkowanej i ciężkiej postaci łuszczycy plackowatej (ICD-10 L 40.0)” w latach 2016–2021.

Published in:

Forum Dermatologicum, 2022, v. 8, n. 3, p. 111, doi. 10.5603/FD.a2022.0021

By:

Noweta, Marcin;
Narbutt, Joanna;
Lesiak, Aleksandra

Publication type:

Article

Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab.

Published in:

Brain Communications, 2022, v. 4, n. 1, p. 1, doi. 10.1093/braincomms/fcab292

By:

Rosenkranz, Sina C.;
Häußler, Vivien;
Kolster, Manuela;
Willing, Anne;
Matschke, Jakob;
Röcken, Christoph;
Stürner, Klarissa;
Leypoldt, Frank;
Tolosa, Eva;
Friese, Manuel A.

Publication type:

Article

Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease.

Published in:

Eye (0950-222X), 2014, v. 28, n. 9, p. 1100, doi. 10.1038/eye.2014.138

By:

Keino, H;
Okada, A A;
Watanabe, T;
Taki, W

Publication type:

Article

Switching biologic agents for uveitis.

Published in:

Eye (0950-222X), 2009, v. 23, n. 9, p. 1868, doi. 10.1038/eye.2009.203

By:

Dhingra, N.;
Morgan, J.;
Dick, A. D.

Publication type:

Article

Surgically induced necrotising scleritis following three-port pars plana vitrectomy without scleral buckling: a series of three cases.

Published in:

Eye (0950-222X), 2008, v. 22, n. 1, p. 162, doi. 10.1038/sj.eye.6702708

By:

Morley, A. M. S.;
Pavesio, C.

Publication type:

Article

Long-term treatment of refractory posterior uveitis with anti-TNFα (infliximab).

Published in:

Eye (0950-222X), 2005, v. 19, n. 8, p. 841, doi. 10.1038/sj.eye.6701689

By:

Benitez-del-Castillo, J. M.;
Martinez-de-la-Casa, J. M.;
Pato-Cour, E.;
Méndez-Fernández, R.;
López-Abad, C.;
Matilla, M.;
Garcia-Sanchez, J.

Publication type:

Article

The successful use of infliximab in resistant relapsing polychondritis and associated scleritis.

Published in:

2005

By:

Cazabon, S.;
Over, K.;
Butcher, J.

Publication type:

Letter

A159 ANTI-TUMOR NECROSIS FACTOR THERAPY PERSISTENCE IN PATIENTS WITH PERIANAL CROHN'S DISEASE AND LUMINAL CROHN'S DISEASE: A COMPARATIVE COHORT STUDY.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 166, doi. 10.1093/jcag/gwab002.157

By:

Fung, M;
Siw, K Chin Koon;
McCurdy, J D

Publication type:

Article

A156 SERUM TUMOUR NECROSIS FACTOR-α ANTAGONIST DRUG CONCENTRATIONS IN PATIENTS WITH PYODERMA GANGRENOSUM ASSOSCIATED WITH INFLAMMATORY BOWEL DISEASE.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 162, doi. 10.1093/jcag/gwab002.154

By:

Mikail, M;
Wilson, A

Publication type:

Article

A150 INFLIXIMAB INDUCED EOSINOPHILIC PNEUMONITIS IN AN ADOLESCENT.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 152, doi. 10.1093/jcag/gwab002.148

By:

Carrión-Jaramillo, E;
Chilvers, M;
Barker, C

Publication type:

Article

A56 CLINICAL AND BIOCHEMICAL EFFICACY ARE NOT AFFECTED BY SWITCH FROM INFLIXIMAB ORIGINATOR TO RENFLEXIS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 13, doi. 10.1093/jcag/gwab002.054

By:

Rosborough, K;
Yu, G;
Barker, C;
Jacobson, K;
Lawrence, S

Publication type:

Article

A Cost-Utility Analysis of Switching from Reference to Biosimilar Infliximab Compared to Maintaining Reference Infliximab in Adult Patients with Crohn's Disease.

Published in:

Journal of the Canadian Association of Gastroenterology, 2021, v. 4, n. 1, p. 48, doi. 10.1093/jcag/gwz045

By:

Hughes, Avery;
Marshall, John K;
Moretti, Myla E;
Ungar, Wendy J

Publication type:

Article

Erratum.

Published in:

2021

By:

Hughes, Avery;
Marshall, John K;
Moretti, Myla E;
Ungar, Wendy J

Publication type:

Correction Notice

Efficacy of mitomycin-C and infliximab in reducing adhesion and fibrosis following strabismus surgery.

Published in:

Turkish Journal of Medical Sciences, 2016, v. 46, n. 5, p. 1401, doi. 10.3906/sag-1506-45

By:

GÜÇLÜ, Emin Serbülent;
SARI, Ayşe Ayça;
DİNÇ, Erdem;
ÖZCAN METİN, Tuba;
ÇOŞKUN YILMAZ, Banu;
TAŞDELEN, Bahar

Publication type:

Article

INFLIXIMAB BIOSIMILAR VERSUS METHOTREXATE FOR THE TREATMENT OF MODERATE TO SEVERE PSORIASIS.

Published in:

Farmacia, 2017, v. 65, n. 6, p. 962

By:

SÂRBU, MARIA-ISABELA;
TAMPA, MIRCEA;
MATEI, CLARA;
MITRAN, CRISTINA-IULIA;
MITRAN1,2#,MITRAN, MĂDĂLINA-IRINA;
PIŢURU, SILVIU;
POP, CORINA SILVIA;
ŞARAMET, GABRIEL;
GEORGESCU, SIMONA-ROXANA

Publication type:

Article

Is intra-articular infliximab therapy a good alternative to radionuclide synovectomy for a patient with refractory pigmented villonodular synovitis?

Published in:

Rheumatology / Reumatologia, 2021, v. 59, n. 5, p. 340, doi. 10.5114/reum.2021.110601

By:

Felis-Giemza, Anna;
Apanel-Kotarska, Anna;
Chojnowski, Marek;
Olesińska, Marzena

Publication type:

Article

Biosimilar infliximab versus originator in Crohn's disease anti-TNF-α naïve and non-naïve patients.

Published in:

Gastroenterology Review / Przegląd Gastroenterologiczny, 2021, v. 16, n. 3, p. 207, doi. 10.5114/pg.2020.100750

By:

Kaniewska, Magdalena;
Rosolowski, Mariusz;
Moniuszko, Andrzej;
Rydzewska, Grazyna

Publication type:

Article

The impact of induction therapy with three doses of infliximab on deep histological healing in paediatric patients with active Crohn's disease.

Published in:

Gastroenterology Review / Przegląd Gastroenterologiczny, 2016, v. 11, n. 3, p. 176, doi. 10.5114/pg.2016.57753

By:

Szymanska, Edyta;
Dadalski, Maciej;
Szymanska, Sylwia;
Grajkowska, Wieslawa;
Pronicki, Maciej;
Kierkus, Jaroslaw

Publication type:

Article

Economic implications of biological therapy for Crohn's disease.

Published in:

Gastroenterology Review / Przegląd Gastroenterologiczny, 2015, v. 10, n. 4, p. 197, doi. 10.5114/pg.2015.55749

By:

Petryszyn, Paweł W.;
Paradowski, Leszek

Publication type:

Article

Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice.

Published in:

2016

By:

Shear, N.;
Hartmann, M.;
Toledo-Bahena, M.;
Gilbert, M.;
Katsambas, A.;
Yao, R.;
Popmihajlov, Z.;
Shear, N H;
Toledo-Bahena, M E

Publication type:

journal article

Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis-Mass Spectrometry.

Published in:

LC-GC Europe, 2019, v. 32, n. 3, p. 130

By:

Michalíková, Klára;
Dominguez-Vega, Elena;
Somsen, Govert W.;
Haselberg, Rob

Publication type:

Article

Artesunate, imatinib, and infliximab in COVID‐19: A rapid review and meta‐analysis of current evidence.

Published in:

Immunity, Inflammation & Disease, 2022, v. 10, n. 6, p. 1, doi. 10.1002/iid3.628

By:

Amani, Bahman;
Zareei, Sara;
Amani, Behnam;
Zareei, Mahsa;
Zareei, Neda;
Shabestan, Rouhollah;
Akbarzadeh, Arash

Publication type:

Article

A Meta-Analysis of Efficacy and Safety of Infliximab for Prevention of Postoperative Recurrence in Patients with Crohn's Disease.

Published in:

BioMed Research International, 2018, p. 1, doi. 10.1155/2018/2615978

By:

Huang, He;
Xu, Su;
Huang, Fubin;
Wang, Xia;
Chen, Yong;
Xu, Zhaoshan

Publication type:

Article

Clinical Snippet.

Published in:: Experimental Dermatology, 2013, v. 22, n. 9, p. iv, doi. 10.1111/j.1600-0625.2013.00245.x
Publication type:: Article